Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles

Pharmazie

Volumn 66, Issue 1, 2011, Pages 24-30

  Pilanya, Urmila ^a   Pilaniya, K ^b   Chandrawanshi, H K ^a   Gupta, N ^c   Rajput, M S ^d  

^a VNS Institute of Pharmacy   (India)

^b Shivdan Singh Institute of Technology and Management   (India)

^c IPS Acadmey ^*  (India)

^d SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; SOLID LIPID NANOPARTICLE; SORBITAN STEARATE; SURFACTANT; VERAPAMIL; WATER; ACID; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; GLYCEROL; LIPID; POLYGLYCEROL MONOSTEARATE; STEARIC ACID DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SCREENING; EMULSION; ENCAPSULATION; EVAPORATION; GASTROINTESTINAL SYMPTOM; IN VITRO STUDY; PARTICLE SIZE; TEMPERATURE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; INSTRUMENT STERILIZATION; MATERIALS TESTING; PH; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; VISCOSITY;

ACIDS; CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EMULSIONS; GLYCEROL; HYDROGEN-ION CONCENTRATION; LIPIDS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; STEARATES; STERILIZATION; SURFACE PROPERTIES; VERAPAMIL; VISCOSITY;

EID: 79953323955     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0061     Document Type: Article

References (29)

1. Arshady R (1990) Albumin microparticles and microcapsules: methodology of manufacturing techniques. J Control Release 14: 111-114.
2. Brakland C, Pollauf E (2007) Macromolecule release from monodisperse PLG microparticles: control of release rates and investigation of release medium. J Pharm Sci 96: 1182-1183.
3. Bonferoni MC, Rossi S, Ferrari F, Stavik E, Pena-Romero A, Caramella C (2000) Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech 1: 15-30.
4. Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR (2003) Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J Pharm Sci 92: 1085-1094. (Pubitemid 36523455)
5. Cavalli R, Caputo O, Parlotti ME, Trotta M, Scarnecchia C, Gasco MR (1997) Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm 148: 47-54. (Pubitemid 27152216)
6. Eldem T, Speiser P, Hincal A (1991) Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 8: 47-54.
7. Erni C, Suard C, Freitas S, Dreher D, Merkle HP, Elke W (2002) Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials 23: 4667-4676. (Pubitemid 36151619)
8. Esposito E, Menegatti E, Cortesi R (2005) Hyaluronan-based microparticles as tools for drug delivery: a comparative study. Int J Pharm 288: 35-49. (Pubitemid 39656453)
9. th edition 712-713.
10. Hu FQ, Yuan H, Zhang HH, Fang M (2002) Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 239: 121-128. (Pubitemid 34615801)
11. Indian Pharmacopoeia (1996) Government of India, Ministry of Health & Family welfare, published by controller of publications, Delhi Vol. II, 797.
12. Krishnan PVV, Venkataman K (2003) Current Index of Medical Specialities 235.
13. Kunisawa J, Okudaira A, Tsutusmi Y (2000) Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses. Vaccine 19: 589-594.
14. Lippacher A, Muller RH, Mader K (2001) Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm 214: 9-12. (Pubitemid 32244069)
15. Martindale (2005) The Complete Drug Reference 34th Edition, Pharmaceutical Press. New York, p. 325.
16. Morel S, Ugazio E, Cavalli R, Gasco MR (1996) Thymopentin in solid lipid nanoparticles. Int J Pharm 132: 259-261. (Pubitemid 26158724)
17. Muller RH, Mehnert W, Lucks JS (1995) Solid lipid nanoparticles: an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41: 62-69.
18. Muller RH, Mader K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm 50: 161-177. (Pubitemid 30326695)
19. Palmieri GF, Bonacucina G, Martino PD, Martelli S (2002) Gastro-resistant microspheres containing ketoprofen. J Microencapsul 19: 111-119. (Pubitemid 34083466)
20. Rafati H, Coombes AGA, Adler J, Holland J, Davis SS (1997) Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J Control Release 43: 89-102. (Pubitemid 26393612)
21. Reithmeier H, Hermann J, Göpferich A (2001) Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 218: 133-143. (Pubitemid 32406164)
22. Reithmeier H, Herrmann J, Göpferich A (2001) Lipid microparticles as a parenteral controlled release device for peptides. J Control Release 73: 339-350. (Pubitemid 32539261)
23. Savolainen M, Herder J, Khoo C (2003) Evaluation of polar lipidhydrophilic polymer microparticles. Int J Pharm 262: 47-62. (Pubitemid 36966693)
24. Schwarz C, Mehnert W, Lucks JS, Müller RH (1994) Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 30: 83-96. (Pubitemid 24173181)
25. Schwarz C, Mehnert W, Lucks JS, Müller RH (1994) Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 30: 83-96. (Pubitemid 24173181)
26. Severine J, Geraldine P, Luc D, Brigitte E (2005) Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opinion Drug Deliv 2: 1-12.
27. Wissing SA, Müller RH (2001) Solid lipid nanoparticles (SLN): a novel carrier for UV blockers. Pharmazie 56: 783-786. (Pubitemid 32971277)
28. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ (1999) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 59: 299-307. (Pubitemid 29238174)
29. zur Mühlen A, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 45: 149-155.